Today: 8 April 2026
Subscribe

Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas shares jumped 28% to C$12.23 on the TSX by midday Friday, hitting a 52-week high after the U.S. Department of Energy took a 5% equity stake and restructured a $2.26 billion loan for the Thacker Pass project. Trading volume topped 2.47 million shares. LAC agreed to draw an initial $435 million tranche of the loan. Analysts remain cautious, noting the company is still pre-revenue.
3 October 2025
··
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc. (QUBT) shares traded near $19.98 on Oct. 3, up about 5% after rebounding from an 11.4% drop the previous day. The stock has swung between $0.65 and $27.15 over the past year, with trading volume surging to 45 million shares on Oct. 2. QUBT completed a $500 million private placement in late September and debuted a new product at the ECOC conference. CEO Bill McGann retired in May; Dr. Yuping Huang is interim CEO.
3 October 2025
··
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir Stock Skyrockets on Boeing AI Partnership – Analysts Weigh In

Palantir shares traded near $184.50 at 9:48 a.m. ET on Oct. 3, down 1.4% but still close to record highs after a Boeing Defense partnership announcement last week. The stock has more than doubled year-to-date, boosted by record Q2 revenue and raised full-year guidance. Analyst targets range from $45 to $215, with consensus around $125–$140. Trading volume remains elevated amid heavy investor interest.
3 October 2025
···
Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast shares closed at $17.02 on Oct. 2, up 4.6% after the FDA-approved Ryoncil won permanent CMS reimbursement via a new J-code. The company confirmed its cell therapies are made from U.S. donors and not subject to tariffs. Wall Street consensus is “Buy” with a $24 average price target. Hedge funds have increased stakes, but overall institutional ownership remains low.
3 October 2025
··
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth (USAR) Stock Explodes on Trump Admin Talks, $100M UK Acquisition & Rare Earth Rally

USA Rare Earth (NASDAQ: USAR) closed at $22.71 on Oct 2, up 23% with record volume, and traded near $25–26 pre-market Oct 3 after hitting a 52-week high. The surge followed news of CEO Barbara Humpton’s appointment, White House talks, and a $100 million UK acquisition. Shares have gained 98% year-to-date, with a market cap of $2.6 billion. Analyst targets lag current prices, signaling possible volatility.
3 October 2025
··
Rezolve AI PLC (RZLV) Stock Skyrockets: The Real Story Behind the Surge (Hint: Rezolve AI)

Market Madness: RZLV (Direxion 2X S&P ETF) Soars With Record Highs

The Direxion 2× S&P 500 Bull ETF (SPUU) traded near $182 midday Oct 3, flat to slightly higher, mirroring the S&P 500’s record close at 6,715 on Oct 2. U.S. stocks hit new highs despite a government shutdown and weak jobs data, with investors anticipating Fed rate cuts. Analysts warn of possible pullbacks after steep tech-led gains. Yahoo’s RZLV ticker refers to Rezolve AI PLC, unrelated to SPUU.
3 October 2025
····
Cipher Mining (CIFR) Skyrockets on Google-Backed AI Deal & Bitcoin Boom – What to Know Now

Google-Backed AI Deal Sends Cipher Mining (CIFR) Stock Soaring – Is $20 Next?

Cipher Mining (CIFR) closed at $13.81 on Oct. 2, up 9.6% on record volume, with pre-market trading near $14.5 and a market cap around $5.4 billion. The stock has surged about 480% in six months, fueled by Bitcoin’s rally and a $3B AI hosting deal with Fluidstack, underwritten in part by Google. Q2 revenue was $44M with a net loss of $46M. Analysts’ average price target is $15.2.
3 October 2025
··
PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

Plug Power PLUG Stock Rockets to 52-Week High on Hydrogen Breakthrough – Is the Rally Sustainable?

Plug Power closed at $2.83 on Oct 2, down 3.41%, with trading volume surging to 121 million shares. The U.S. Department of Energy canceled $75 million in planned hydrogen grants for the company, citing lack of alignment with national energy needs. Plug delivered its first 10 MW electrolyzer to Galp’s Sines Refinery in Portugal and reported record hydrogen output at its Georgia plant in August.
3 October 2025
·
GameStop’s Shocking 2025 Comeback: Crypto Bets, Trading Cards & Meme-Stock Mania Fuel GME Rally

GameStop (GME) Stock Surges Again – What’s Driving the October 2025 Rally?

GameStop closed at $27.22 on Oct. 2, up from its 52-week low but below its recent high. The company executed an 11-for-10 stock split and distributed 1-for-10 warrants effective Oct. 3, while filing a mixed shelf registration to raise capital. Q2 net income surged to $168.6 million on $972.2 million sales, boosted by cost cuts and crypto gains. Analyst consensus rates the stock a Sell, with a $13.50 average price target.
3 October 2025
·
AST SpaceMobile Stock Skyrockets on Satellite Breakthroughs and Big-Name Backing

AST SpaceMobile Soars on Satellite Breakthrough: What’s Behind $ASTS’s 16% Rally?

AST SpaceMobile shares soared 16% on Oct 1 and again 16% on Oct 2, closing at $66.16 on heavy volume after announcing its BlueBird-6 satellite is ready for launch by year-end. The company targets 45–60 satellites in orbit by 2026 and partners with carriers including AT&T, Verizon, and Vodafone. Barclays raised its price target to $60, while UBS cut to $43. Market cap stands near $20–24 billion.
3 October 2025
··
Rigetti (RGTI) Quantum Computing Stock Soars on Major Orders and Partnerships

Rigetti (RGTI) Quantum Computing Stock Soars on Major Orders and Partnerships

Rigetti shares surged to $35.40 on Oct. 2, up 18.6% in heavy trading after announcing $5.7 million in new quantum computer orders. The company also secured a $5.8 million U.S. Air Force contract in September and expanded partnerships with Quanta Computer and India’s C-DAC. In August, Rigetti launched a 36-qubit system and reported $1.8 million Q2 revenue, with $571.6 million cash after a $350 million equity raise.
3 October 2025
··
Fair Isaac Corp’s 2025 Surge: How a Direct‑to‑Lender Move Disrupted Credit Bureaus and Re‑Energized FICO Stock

Credit-Score Shake-Up! FICO Stock Rockets 20% on Game-Changing Strategy

FICO shares surged up to 23% in early October 2025 after launching a direct licensing model for its credit scores, bypassing credit bureaus. Q3 revenue rose 20% to $536.4 million, with net income at $181.8 million. Equifax, Experian, and TransUnion stocks fell as analysts warned of profit hits. FICO’s market cap reached $46 billion, with a trailing P/E of 69.
3 October 2025
····
Sarepta Therapeutics Stock Skyrockets After FDA U-Turn – Gene Therapy Drama Explained

Sarepta Therapeutics Stock Skyrockets After FDA U-Turn – Gene Therapy Drama Explained

The FDA on July 28, 2025, cleared Elevidys gene therapy shipments for ambulatory patients after finding no link to a child’s death, while Sarepta added black-box liver warnings. Sarepta’s Q2 revenue jumped 68% to $611.1 million, but shares plunged 85% YTD before rebounding to $22.35 after the FDA decision. The EU’s CHMP issued a negative opinion on Elevidys, delaying European approval. Sarepta cut 36% of its workforce in July.
3 October 2025
··
Circle (CRCL) Stock Soars on Stablecoin Boom – Investors Buzz Over Crypto Partnerships

Circle (CRCL) Stock Soars on Stablecoin Boom – Investors Buzz Over Crypto Partnerships

Circle Internet Group (NYSE: CRCL), issuer of USDC and EURC, went public in June 2025 at $31 per share and surged to nearly $200 after U.S. stablecoin legislation passed. The company reported Q2 revenue of $1.67 billion but a net loss of $482 million. CRCL stock rose 17.7% on Oct 2, 2025, after announcing new partnerships. Analysts remain split, with price targets ranging from $136 to $243.
3 October 2025
···
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Skyrocketing Ondas (NASDAQ:ONDS) Stock: 26% Surge on $3.5M Drone Deal – What Investors Must Know

ONDS shares jumped 26% to close at $9.21 on Oct 2, 2025, after the company ordered 500 Wasp drones from Rift Dynamics and announced new defense contracts. Market cap reached about $3 billion. Ondas posted Q2 revenue of $6.27 million with a $12 million net loss. Analysts rate the stock a “Strong Buy” but set an average target of $5.67, well below current levels.
3 October 2025
···
Rezolve AI PLC (RZLV) Stock Skyrockets: The Real Story Behind the Surge (Hint: Rezolve AI)

Rezolve AI PLC (RZLV) Stock Skyrockets: The Real Story Behind the Surge (Hint: Rezolve AI)

Rezolve AI (RZLV) reported H1 2025 revenue of $6.3M, up 426% year-over-year, with gross margin near 96%. Shares surged 24% on Oct. 2 after the company raised its 2025 ARR target to $150M and set a $500M goal for 2026. Multiple analysts upgraded price targets following the results. Market cap stands near $1.4B, but Rezolve remains unprofitable with a high price/sales ratio and tight liquidity.
3 October 2025
···
1 … 1,700 1,701 1,702 1,703 1,704 … 1,845

Stock Market Today

  • 4 FTSE 250 Shares Offering High Dividend Yields for Monthly Income
    April 8, 2026, 4:58 AM EDT. Investors seeking a four-figure monthly passive income may target FTSE 250 stocks with dividend yields around double the average 3.52%. Four notable picks include Chesnara (7.73% yield), Supermarket Income REIT (7.64%), Primary Health Properties (7.79%), and Aberdeen Group, which offers a 7.48% yield alongside a 53% share price rise over the past year. Chesnara benefits from steady pension cash flows, Supermarket Income REIT leases to major UK grocers on inflation-linked contracts, and Primary Health focuses on healthcare properties with government-backed rents. Regular £600 monthly investments in average 7% yield stocks could generate £1,000 monthly dividends within 15 years. Risks vary per stock and tax implications depend on individual circumstances.
Go toTop